Brief: Mineralys Therapeutics Q4 EPS USD -0.4
12/03/2026 20:05
Mar 12 (Reuters) - Mineralys Therapeutics Q4 net income USD -32.234 million. Q4 operating income USD -38.28 million Q4 operating expenses USD 38.28 million
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway